About Orca Bio
Orca Bio is a company based in Menlo Park (United States) founded in 2016 by Jeroen Bekaert and Ivan Dimov.. Orca Bio has raised $442 million across 2 funding rounds from investors including Kaiser Permanente, Lightspeed Venture Partners and Mubadala. The company has 66 employees as of December 31, 2021. Orca Bio offers products and services including Orca-T and Orca-Q. Orca Bio operates in a competitive market with competitors including Moderna, Horizon Therapeutics, Forge Biologics, argenx and Annexon, among others.
- Headquarter Menlo Park, United States
- Employees 66 as on 31 Dec, 2021
- Founders Jeroen Bekaert, Ivan Dimov
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$442 M (USD)
in 2 rounds
-
Latest Funding Round
$250 M (USD), Series F
Jan 09, 2026
-
Investors
Kaiser Permanente
& 6 more
-
Employee Count
66
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Orca Bio
Orca Bio offers a comprehensive portfolio of products and services, including Orca-T and Orca-Q. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Investigational therapy targeting cancer with high-precision T-cells
Investigational therapy for autoimmune diseases using advanced cells
Unlock access to complete
Unlock access to complete
Software Development Team
18 people
Product Management Team
8 people
Advisor Team
7 people
Manufacturing Team
7 people
Leadership Team
6 people
Operations Team
5 people
Data Analysis and Operations Team
5 people
Human Resources and Administration
4 people
Unlock access to complete
Funding Insights of Orca Bio
Orca Bio has successfully raised a total of $442M across 2 strategic funding rounds. The most recent funding activity was a Series F round of $250 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series F — $250.0M
-
First Round
First Round
(29 Nov 2019)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2026 | Amount | Series F - Orca Bio | Valuation | Lightspeed Venture Partners |
|
| Nov, 2019 | Amount | Series D - Orca Bio | Valuation | Lightspeed Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Orca Bio
Orca Bio has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Kaiser Permanente, Lightspeed Venture Partners and Mubadala. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investing in innovative companies across global sectors is undertaken by Lightspeed Venture Partners.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in technology, life sciences, and related sectors.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Orca Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Orca Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Orca Bio Comparisons
Competitors of Orca Bio
Orca Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Horizon Therapeutics, Forge Biologics, argenx and Annexon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Therapeutics for autoimmune diseases are developed by the company.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Orca Bio
Frequently Asked Questions about Orca Bio
When was Orca Bio founded?
Orca Bio was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Where is Orca Bio located?
Orca Bio is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Who is the current CEO of Orca Bio?
Ivan Dimov is the current CEO of Orca Bio. They have also founded this company.
Is Orca Bio a funded company?
Orca Bio is a funded company, having raised a total of $442M across 2 funding rounds to date. The company's 1st funding round was a Series D of $192M, raised on Nov 29, 2019.
How many employees does Orca Bio have?
As of Dec 31, 2021, the latest employee count at Orca Bio is 66.
What does Orca Bio do?
Orca Bio is a developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders. It uses OrcaSort technology that is an enabling feature for the scalability and high-precision of the manufacturing platform. It also helps in the isolation and purification of stem cells and immune cells used in hematopoietic cell grafts. The components of the technology are optimized for performance and designed to fit seamlessly into the clinical processing of apheresis products. It has developed therapeutic solutions for regulatory T cells that aims to temper the immune reaction. It reduces the fatal complications and provides maximum control of the development of the patients new immune system.
Who are the top competitors of Orca Bio?
Orca Bio's top competitors include Moderna, argenx and Forge Biologics.
What products or services does Orca Bio offer?
Orca Bio offers Orca-T and Orca-Q.
Who are Orca Bio's investors?
Orca Bio has 7 investors. Key investors include Kaiser Permanente, Lightspeed Venture Partners, Mubadala, 8VC, and DCVC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.